Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT07552532

Multimodal CT-Based Risk Stratification for Postoperative Local Recurrence in NSCLC: A Multicenter Study

This multicenter retrospective study is designed to develop and validate a CT-based multimodal risk stratification approach for postoperative local recurrence after curative-intent resection of non-small cell lung cancer (NSCLC). The approach integrates clinicopathologic variables, intratumoral and peritumoral radiomics, tumor-based 2.5D deep learning features, whole-lung deep learning features, and operative text features to capture complementary information related to tumor phenotype, pulmonary background, and surgical findings. Predictive performance and clinical utility will be evaluated in internal and external validation cohorts using the concordance index, time-dependent area under the receiver operating characteristic curve, decision curve analysis, and risk reclassification analyses. The objective of this study is to assess whether multimodal CT-based risk stratification may improve postoperative risk assessment and support individualized surveillance and management strategies.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Jinling Hospital

Nanjing, Jiangsu, 210002, China

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Pathologically confirmed non-small cell lung cancer (NSCLC)
  • Preoperative contrast-enhanced chest CT performed within 2 weeks before surgery
  • Underwent routine postoperative follow-up

Exclusion criteria

  • Small cell lung cancer or metastatic tumors
  • Incomplete resection (R1/R2)
  • No preoperative contrast-enhanced CT performed within 2 weeks before surgery
  • History of other malignancies
  • Inadequate follow-up or follow-up duration of 3 months or less

Treatment and study plan

Primary outcomes

  1. Postoperative local recurrence

    Time frame: From the date of surgery to first documented local recurrence, up to 3 years

Sponsors and collaborators

Lead sponsor

Guangming Lu

Other

Registry information

Official study title

Multimodal CT-Based Risk Stratification of Postoperative Local Recurrence in Non-Small Cell Lung Cancer: A Multicenter Study

Important dates

Study start
2023
Primary completion
2026
Study completion
2026
First posted
Apr 27, 2026
Registry last updated
Apr 27, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.